Detalhe da pesquisa
1.
Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials.
Am J Psychiatry
; 156(7): 990-9, 1999 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10401441
2.
Efficacy of beta-blocker supplementation for schizophrenia: a systematic review of randomized trials.
Schizophr Res
; 41(2): 341-7, 2000 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-10708343
3.
Risperidone versus clozapine in treatment-resistant schizophrenia: a randomized pilot study.
Prog Neuropsychopharmacol Biol Psychiatry
; 24(6): 911-22, 2000 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-11041534
4.
Beta-blocker supplementation of standard drug treatment for schizophrenia.
Cochrane Database Syst Rev
; (3): CD000234, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-10908467
5.
Beta-blocker supplementation of standard drug treatment for schizophrenia.
Cochrane Database Syst Rev
; (2): CD000234, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-10796332
6.
Beta-blocker supplementation of standard drug treatment for schizophrenia.
Cochrane Database Syst Rev
; (3): CD000234, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11686955
7.
Clozapine versus typical neuroleptic medication for schizophrenia.
Cochrane Database Syst Rev
; (2): CD000059, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-10796289
8.
Pharmacological treatment of schizophrenia resistant to first-line treatment: a critical systematic review and meta-analysis.
Int J Psychiatry Clin Pract
; 3(3): 159-69, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-24927201